-
Subject Areas on Research
-
A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis.
-
A cluster of virus-encoded microRNAs accelerates acute systemic Epstein-Barr virus infection but does not significantly enhance virus-induced oncogenesis in vivo.
-
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.
-
A human anti-HIV autoantibody enhances EBV transformation and HIV infection.
-
A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
-
A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.
-
A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus.
-
Acute leukemia in Burkitt lymphoma.
-
Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma.
-
Adoptively transferred immunity persists in human marrow graft recipients.
-
Age-related patterns of cytomegalovirus antibodies accompanying Epstein-Barr virus co-infection.
-
An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells.
-
An Epstein-Barr virus-positive classical Hodgkin lymphoma with exclusive sinusoidal growth pattern: An unusual morphologic variant.
-
An uncommon presentation of non-Hodgkin's lymphoma in a renal transplant recipient.
-
Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation.
-
Anti-EBV serologic tests for nasopharyngeal carcinoma.
-
Antibody-dependent cellular cytotoxicity and disease course in North American patients with nasopharyngeal carcinoma: a prospective study.
-
Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma.
-
Application of Epstein-Barr virus serology to the diagnosis and staging of North American patients with nasopharyngeal carcinoma.
-
Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype.
-
Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases.
-
Characterization of an Epstein-Barr virus receptor on human epithelial cells.
-
Characterization of the EBV-Induced Persistent DNA Damage Response.
-
Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis.
-
Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases.
-
Combined assessment of Epstein-Barr virus viral capsid antigen and Epstein-Barr virus nuclear antigen-1 serology for post-transplant lymphoproliferative disorder risk stratification in adult solid organ transplant recipients.
-
Comprehensive epitope mapping of the Epstein-Barr virus latent membrane protein-2 in normal, non tumor-bearing individuals.
-
Comprehensive molecular characterization of gastric adenocarcinoma.
-
Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
-
Correlation between interferon- gamma secretion and cytotoxicity, in virus-specific memory T cells.
-
Dendritic cells improve the generation of Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of posttransplantation lymphoma.
-
Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
-
Detection of polyomavirus SV40 in tonsils from immunocompetent children.
-
Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems.
-
Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
-
Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation.
-
EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival.
-
EBV Noncoding RNAs.
-
EBV+ high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional study.
-
EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management.
-
EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
-
EBV-positive diffuse large B-cell lymphoma of the elderly.
-
EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.
-
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management.
-
Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry.
-
Effects of cyclosporine on human B-cell lymphoma development in vivo.
-
Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis.
-
Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells.
-
Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
-
Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.
-
Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia.
-
Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients.
-
Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma.
-
Epstein-Barr Viruses (EBVs) Deficient in EBV-Encoded RNAs Have Higher Levels of Latent Membrane Protein 2 RNA Expression in Lymphoblastoid Cell Lines and Efficiently Establish Persistent Infections in Humanized Mice.
-
Epstein-Barr in acute nontraumatic mononeuropathies.
-
Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity.
-
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival.
-
Epstein-Barr virus and Guillain-Barrè syndrome.
-
Epstein-Barr virus and the elderly host.
-
Epstein-Barr virus antibodies in whole blood spots: a minimally invasive method for assessing an aspect of cell-mediated immunity.
-
Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection.
-
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.
-
Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.
-
Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
-
Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.
-
Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed.
-
Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes in vitro.
-
Epstein-Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes.
-
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
-
Epstein-Barr virus-associated epithelial and mesenchymal neoplasms.
-
Epstein-Barr virus-associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma.
-
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
-
Epstein-Barr virus-associated smooth muscle tumor involving the spine of an HIV-infected patient: Case report and review of the literature.
-
Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients.
-
Epstein-Barr virus-negative diffuse large B cell lymphoma with aberrant expression of CD3 and other T cell-associated antigens: report of three cases with a review of the literature.
-
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
-
Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection.
-
Establishment of stably EBV-transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing.
-
Evidence of Epstein-Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorder.
-
Evolutionary conservation of primate lymphocryptovirus microRNA targets.
-
Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings.
-
Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus.
-
Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma.
-
High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.
-
High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies.
-
Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus.
-
Human epithelial cell expression of an Epstein-Barr virus receptor.
-
Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics.
-
Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.
-
Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III.
-
Improved EBV shuttle vectors.
-
In situ detection of Epstein-Barr virus in non-small cell lung carcinomas.
-
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
-
Isolation of human sequences that replicate autonomously in human cells.
-
Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up.
-
Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling.
-
Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach.
-
Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.
-
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
-
Lymphoproliferative disorders: CT findings in immunocompromised children.
-
MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival.
-
Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation.
-
Meralgia paraesthetica and Epstein-Barr virus.
-
Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization.
-
Molecular analysis of thymopentin binding to HLA-DR molecules.
-
Molecular basis of latency in pathogenic human viruses.
-
Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes.
-
Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas.
-
Multilocular thymic cysts in children with human immunodeficiency virus infection: clinical and pathologic aspects.
-
Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product.
-
Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta).
-
Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
-
Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation.
-
Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis.
-
Preexposure of resting B cells to interferon-gamma enhances their proliferative response to subsequent activation signals.
-
Proteins of purified Epstein-Barr virus.
-
Reactivation of Epstein-Barr Virus by HIF-1α Requires p53.
-
Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.
-
Replication control of autonomously replicating human sequences.
-
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia.
-
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.
-
Role of Epstein-Barr virus infection in SLE: gene-environment interactions at the molecular level.
-
Single-cell RNA-seq reveals transcriptomic heterogeneity mediated by host-pathogen dynamics in lymphoblastoid cell lines.
-
SplicerEX: a tool for the automated detection and classification of mRNA changes from conventional and splice-sensitive microarray expression data.
-
Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes.
-
Successful immune reconstitution in severe combined immunodeficiency despite Epstein-Barr virus and cytomegalovirus infections.
-
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.
-
T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
-
TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma.
-
The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
-
The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis.
-
The Mediating Role of Meaning in the Association between Stress and Health.
-
The Role of EBV in the Pathogenesis of Diffuse Large B Cell Lymphoma.
-
The Role of EBV-Induced Hypermethylation in Gastric Cancer Tumorigenesis.
-
The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA.
-
The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes.
-
The role of Epstein-Barr virus in systemic lupus erythematosus.
-
The role of microRNAs in Epstein-Barr virus latency and lytic reactivation.
-
The role of monogamous bivalency and Fc interactions in the binding of anti-DNA antibodies to DNA antigen.
-
The viral and cellular microRNA targetome in lymphoblastoid cell lines.
-
Time-resolved transcriptomes reveal diverse B cell fate trajectories in the early response to Epstein-Barr virus infection.
-
To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis.
-
Transformation of hairy cell leukemia to EBV genome-containing aggressive B cell lymphoma.
-
Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus.
-
Viral Micro-RNAs Are Detected in the Early Systemic Response to Injury and Are Associated With Outcomes in Polytrauma Patients.
-
Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus.
-
[Studies on human porin. V. The expression of "porin31HL" in the plasmalemma is not by cell transformation].
-
c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
-
Keywords of People